Managing Closely Excised Nonmelanoma Skin Cancer.

Sebastian Kosasih, Chrysavgi Mavrokefalou, Shahab Shahid, Naguib El-Muttardi, Ben Miranda

Abstract read

In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sebastian KosasihAll authors are with St. Andrew's Centre for Plastic Surgery & Burns, Broomfield Hospital, Chelmsford, United Kingdom.

Chrysavgi MavrokefalouAll authors are with St. Andrew's Centre for Plastic Surgery & Burns, Broomfield Hospital, Chelmsford, United Kingdom.

Shahab ShahidAll authors are with St. Andrew's Centre for Plastic Surgery & Burns, Broomfield Hospital, Chelmsford, United Kingdom.

Naguib El-MuttardiAll authors are with St. Andrew's Centre for Plastic Surgery & Burns, Broomfield Hospital, Chelmsford, United Kingdom.

Ben MirandaAll authors are with St. Andrew's Centre for Plastic Surgery & Burns, Broomfield Hospital, Chelmsford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of nonmelanoma skin cancer (NMSC) excision is histologic clearance with margins of ≥1 mm, but evidence for close-margin management is scarce.

backgroundTo compare complete, close, and incomplete excision recurrences.

methodsWe performed a retrospective study of a subset of patients who underwent NMSC excision during 2020 to 2021. Lesions were grouped as complete (≥1 mm clearance), close (<1 mm), or incomplete (involved) and recurrence data were collected. Discrete data were analyzed using a χ

resultsThere were 421 lesions comprising 194 squamous cell carcinomas (SCCs; 49%) and 227 basal cell carcinomas (BCCs; 51%) included in the analysis. The mean follow-up was 29.3 months (standard deviation: 3.2), and the recurrence rate was 5%. There was a significantly greater risk of recurrence in closely (12%) vs completely (3%) excised SCCs (χ LIMITATIONS: Follow-up was <5 years, after which NMSCs may still recur.

conclusionOur results support the clinical practice of treating closely excised SCCs as incomplete and treating closely excised BCCs as complete, perhaps with a follow-up period, in select cases such as when satisfying patient preference or minimising morbidity due to re-excision.

Indexed as

basal cell carcinomaclose excisionNonmelanoma skin cancerrecurrencesquamous cell carcinoma

Identifiers

PMID42761953

PMCPMC13588478

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.